Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G LAWSUIT VS. F&M SEEKS TO END RETAILER'S USE OF ANY TRADE DRESS

This article was originally published in The Tan Sheet

Executive Summary

P&G LAWSUIT VS. F&M SEEKS TO END RETAILER'S USE OF ANY TRADE DRESS "confusingly similar" to Procter & Gamble products in connection with the manufacturing, advertising, promotion and sale of F&M private-label products. In addition, the suit, filed Sept. 7 in the federal district court in Toledo, Ohio, seeks to enjoin F&M from "further diluting, whittling away or blurring the distinctiveness of any [of P&G's] trade dresses or trademarks."

You may also be interested in...



P&G Steps Up Trade Dress Litigation Against Private Labelers

Procter & Gamble has more trade dress and intellectual property litigation against private labelers in the works, the company said during a week it filed a lawsuit against one firm and settled with another

P&G Steps Up Trade Dress Litigation Against Private Labelers

Procter & Gamble has more trade dress and intellectual property litigation against private labelers in the works, the company said during a week it filed a lawsuit against one firm and settled with another

P&G Steps Up Trade Dress Litigation Against Private Labelers

Procter & Gamble has more trade dress and intellectual property litigation against private labelers in the works, the company said during a week it filed a lawsuit against one firm and settled with another

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel